2nd possible carcinogen found in recalled blood pressure drug valsartan, Health Canada says
Thursday, September 13, 2018 - 12:20
in Health & Medicine
A second impurity that is a classified as a probable human carcinogen has been found in valsartan, manufactured by Zhejiang Huahai Pharmaceuticals in China, Health Canada announces.